These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Erythropoietin hypertension: fact or fiction? Dorhout Mees EJ; Ok E Int J Artif Organs; 1997 Aug; 20(8):415-7. PubMed ID: 9323502 [No Abstract] [Full Text] [Related]
4. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M; Rodrigue ME; Agharazii M; Larivière R Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis. Yamakado M; Umezu M; Nagano M; Tagawa H Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212 [TBL] [Abstract][Full Text] [Related]
6. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity]. Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112 [TBL] [Abstract][Full Text] [Related]
8. Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice. Volpe M; Tocci G Expert Rev Cardiovasc Ther; 2010 Jun; 8(6):811-20. PubMed ID: 20528639 [TBL] [Abstract][Full Text] [Related]
9. Erythropoietin-induced hypertension. Ismail N; Ikizler TA J Med Liban; 1997; 45(1):25-30. PubMed ID: 9421942 [No Abstract] [Full Text] [Related]
10. Is there overlap in blood-pressure response to the blockers of the renin-angiotensin system between lower and higher renin subjects? Minami J; Ishimitsu T; Matsuoka H Am J Hypertens; 2008 Feb; 21(2):130-1; author reply 132. PubMed ID: 18268482 [No Abstract] [Full Text] [Related]
11. [Management of arterial hypertension in children (author's transl]. Balboa de Paz F; Rubio Roldán LA; Sánchez Díaz JI An Esp Pediatr; 1981 Dec; 15(6):573-80. PubMed ID: 6121529 [No Abstract] [Full Text] [Related]
12. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension]. Coca A; Redón J Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731 [No Abstract] [Full Text] [Related]
13. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version]. Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J; Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424 [No Abstract] [Full Text] [Related]
14. Cardiorenal interaction: appropriate treatment of cardiovascular risk factors to improve outcomes in chronic kidney disease. McCullough PA; Verrill TA Postgrad Med; 2010 Mar; 122(2):25-34. PubMed ID: 20203453 [TBL] [Abstract][Full Text] [Related]
16. [Hypertensive syndrome in kidney diseases]. Tareeva IE; Kutyrina IM Klin Med (Mosk); 1985 Apr; 63(4):6-12. PubMed ID: 3897700 [No Abstract] [Full Text] [Related]
17. Which antihypertensive drugs are the most nephroprotective and why? Cravedi P; Ruggenenti P; Remuzzi G Expert Opin Pharmacother; 2010 Nov; 11(16):2651-63. PubMed ID: 20977400 [TBL] [Abstract][Full Text] [Related]